The salivary microbiome and oral health status in HBeAg-negative chronic hepatitis B

被引:0
作者
Lu, Liyan [1 ,2 ]
Yan, Lingjun [4 ]
Sohrabi, Amir [5 ]
Lindahl, Karin [6 ,7 ]
Cederberg, Susanne [6 ]
Wang, Raorao [2 ]
Ye, Weimin [5 ,8 ,9 ]
Aleman, Soo [6 ,7 ]
Chen, Margaret Sallberg [1 ,3 ]
机构
[1] Karolinska Inst, Dept Lab Med, Huddinge, Sweden
[2] Tongji Univ, Shanghai Peoples Hosp 10, Dept Stomatol, Shanghai, Peoples R China
[3] Karolinska Inst, Dept Dent Med, Huddinge, Sweden
[4] Fujian Med Univ, Affiliated Hosp 1, Fujian Prov Inst Brain Disorders & Brain Sci, Fuzhou, Peoples R China
[5] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[6] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
[7] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden
[8] Fujian Med Univ, Dept Epidemiol & Hlth Stat, Fuzhou, Peoples R China
[9] Fujian Med Univ, Key Lab Minist Educ Gastrointestinal Canc, Fuzhou, Peoples R China
关键词
Chronic hepatitis B (CHB); Oral health; Oral microbiota; Saliva; 16s rRNA sequencing;
D O I
10.1016/j.jds.2024.08.016
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background/purpose: Dysbiosis of oral microbiota has been reported in late stage of chronic hepatitis B (CHB) infection with cirrhosis. CHB is characterized by the constant virus-induced liver injury which may lead to liver cirrhosis and hepatocellular carcinoma (HCC). However, some patients show normal liver function without antiviral treatment, associating with favourable prognosis. The oral microbiota composition and oral health status in these patients is unidentified. Materials and methods: The study focuses on the composition of oral microbiota and oral health status in individuals with CHB and HBV vaccinees as controls. The CHB patients were hepatitis B 'e' antigen (HBeAg)-negative, with or without elevated liver enzyme increase at time of sampling, The 16S rRNA high-throughput sequencing and bioinformatic analysis were applied to investigate oral bacterial diversity, and oral examination including decay-missing- filled teeth (DMFT) index, probing depth (PD) and mucosal status was performed, along with oral health questionnaire, to assess the oral health status in CHB patients and healthy controls. Results: Our results indicate that their oral microbiome compositions are not significantly different though some have increased ALT/AST liver enzyme levels at the time of sampling, compared to the healthy control participants who are vaccinated e.g. protected from this viral disease. CHB patients here bore a good oral health status and life-style habits as comparing to healthy controls. Conclusion: These findings suggest that a health-associated salivary microflora is present in CHB without severe liver injury. Continued regular dental health and lifestyle support in liver disease patients is therefore justified. <feminine ordinal indicator> 2024 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:S17 / S25
页数:9
相关论文
共 32 条
[1]   Altered Microbiome in Patients With Cirrhosis and Complications [J].
Acharya, Chathur ;
Bajaj, Jasmohan S. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (02) :307-321
[2]   Microbiota, cirrhosis, and the emerging oral-gut-liver axis [J].
Acharya, Chathur ;
Sahingur, Sinem Esra ;
Bajaj, Jasmohan S. .
JCI INSIGHT, 2017, 2 (19)
[3]   The gut-liver axis in liver disease: Pathophysiological basis for therapy [J].
Albillos, Agustin ;
de Gottardi, Andrea ;
Rescigno, Maria .
JOURNAL OF HEPATOLOGY, 2020, 72 (03) :558-577
[4]   Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis [J].
Albuquerque-Souza, Emmanuel ;
Sahingur, Sinem E. .
PERIODONTOLOGY 2000, 2022, 89 (01) :125-141
[5]   HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection [J].
Alexopoulou, Alexandra ;
Karayiannis, Peter .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (24) :7644-7652
[6]   The oral microbiome: diversity, biogeography and human health [J].
Baker, Jonathon L. ;
Welch, Jessica L. Mark ;
Kauffman, Kathryn M. ;
Mclean, Jeffrey S. ;
He, Xuesong .
NATURE REVIEWS MICROBIOLOGY, 2024, 22 (02) :89-104
[7]   Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 [J].
Bolyen, Evan ;
Rideout, Jai Ram ;
Dillon, Matthew R. ;
Bokulich, NicholasA. ;
Abnet, Christian C. ;
Al-Ghalith, Gabriel A. ;
Alexander, Harriet ;
Alm, Eric J. ;
Arumugam, Manimozhiyan ;
Asnicar, Francesco ;
Bai, Yang ;
Bisanz, Jordan E. ;
Bittinger, Kyle ;
Brejnrod, Asker ;
Brislawn, Colin J. ;
Brown, C. Titus ;
Callahan, Benjamin J. ;
Caraballo-Rodriguez, Andres Mauricio ;
Chase, John ;
Cope, Emily K. ;
Da Silva, Ricardo ;
Diener, Christian ;
Dorrestein, Pieter C. ;
Douglas, Gavin M. ;
Durall, Daniel M. ;
Duvallet, Claire ;
Edwardson, Christian F. ;
Ernst, Madeleine ;
Estaki, Mehrbod ;
Fouquier, Jennifer ;
Gauglitz, Julia M. ;
Gibbons, Sean M. ;
Gibson, Deanna L. ;
Gonzalez, Antonio ;
Gorlick, Kestrel ;
Guo, Jiarong ;
Hillmann, Benjamin ;
Holmes, Susan ;
Holste, Hannes ;
Huttenhower, Curtis ;
Huttley, Gavin A. ;
Janssen, Stefan ;
Jarmusch, Alan K. ;
Jiang, Lingjing ;
Kaehler, Benjamin D. ;
Bin Kang, Kyo ;
Keefe, Christopher R. ;
Keim, Paul ;
Kelley, Scott T. ;
Knights, Dan .
NATURE BIOTECHNOLOGY, 2019, 37 (08) :852-857
[8]  
Deo Priya Nimish, 2019, J Oral Maxillofac Pathol, V23, P122, DOI 10.4103/jomfp.JOMFP_304_18
[9]   EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection [J].
Lampertico P. ;
Agarwal K. ;
Berg T. ;
Buti M. ;
Janssen H.L.A. ;
Papatheodoridis G. ;
Zoulim F. ;
Tacke F. .
JOURNAL OF HEPATOLOGY, 2017, 67 (02) :370-398
[10]   Therapeutic strategies for hepatitis B virus infection: towards a cure [J].
Fanning, Gregory C. ;
Zoulim, Fabien ;
Hou, Jinlin ;
Bertoletti, Antonio .
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (11) :827-844